Amundi
IART icon

Amundi’s Integra LifeSciences IART Stock Holding History

Amundi’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$332K Sell
18,470
-960
-5% -$13.4K ﹤0.01% 1813
2026
Q1 		$183K Buy
19,430
+8,681
+81% +$95.3K ﹤0.01% 1898
2025
Q4 		$134K Sell
10,749
-319
-3% -$4.24K ﹤0.01% 1791
2025
Q3 		$160K Hold
11,068
– – ﹤0.01% 1562
2025
Q2 		$150K Buy
11,068
+11,004
+17,194% +$160K ﹤0.01% 1635
2025
Q1 		$1.28K Buy
64
+36
+129% +$847 ﹤0.01% 2010
2024
Q4 		$623 Buy
+28
New +$611 ﹤0.01% 2086
2023
Q1 		– Sell
-1,063
Closed -$61.8K – 2080
2022
Q4 		$61.8K Buy
+1,063
New +$54.1K ﹤0.01% 1670

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Amundi's IART Position: Q2 2026 in Review

Amundi reduced its Integra LifeSciences (IART) stake by 4.9% in Q2 2026, selling an estimated $13.4K and leaving 18,470 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

Amundi first reported a position in IART in Q4 2022 and has held it in 8 quarters since. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Amundi held 18,470 shares of Integra LifeSciences worth $332K as of Q2 2026.
  • Amundi sold 960 Integra LifeSciences shares in Q2 2026, an estimated $13.4K.
  • Integra LifeSciences made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1813 holding.
  • Amundi first reported a position in Integra LifeSciences in Q4 2022 and has held it in 8 quarters since.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.